SOURCE: ISTA Pharmaceuticals

ISTA Pharmaceuticals

April 20, 2011 07:30 ET

ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2011 Financial Results

IRVINE, CA--(Marketwire - Apr 20, 2011) - ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), today announced it will release first quarter 2011 financial results after the market closes on May 4, 2011. In conjunction, the Company will host a conference call to review first quarter results and provide a business update at 4:30 p.m. Eastern Time.

Date: Wednesday, May 4, 2011

Time: 4:30 p.m. Eastern Time

Conference call access:
Domestic dial-in: 866-761-0749
International dial-in: 617-614-2707
Passcode: 51591817

To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 59551940. This conference call also will be webcast live and archived on ISTA's website until June 1, 2011.

About ISTA Pharmaceuticals

ISTA Pharmaceuticals, Inc., is the fourth largest and fastest growing branded prescription eye care business in the United States, with an expanding focus on allergy therapeutics. ISTA currently markets four products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The company's development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain, and nasal allergies. Headquartered in Irvine, California, ISTA generated revenues of $156.5 million in 2010. For additional information about ISTA, please visit the corporate website at

Contact Information